Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.
J Med Chem
; 64(16): 12022-12048, 2021 08 26.
Article
in En
| MEDLINE
| ID: mdl-34351741
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Thiophenes
/
Vascular Endothelial Growth Factor Receptor-3
/
Triple Negative Breast Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2021
Type:
Article
Affiliation country:
China